Insufficient scRNA-seq data for expression of FLG at single-cell level.
Insufficient scRNA-seq data for expression of FLG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 97% | 78911.59 | 1746 / 1809 | 38% | 8.75 | 178 / 472 |
esophagus | 78% | 1710.11 | 1126 / 1445 | 36% | 3.90 | 66 / 183 |
ovary | 89% | 266.83 | 161 / 180 | 15% | 1.52 | 66 / 430 |
uterus | 82% | 283.75 | 140 / 170 | 14% | 1.00 | 65 / 459 |
thymus | 88% | 180.37 | 573 / 653 | 6% | 0.08 | 34 / 605 |
kidney | 71% | 142.02 | 63 / 89 | 11% | 0.34 | 95 / 901 |
adrenal gland | 76% | 185.38 | 195 / 258 | 5% | 0.10 | 12 / 230 |
lung | 64% | 109.58 | 372 / 578 | 8% | 0.19 | 92 / 1155 |
pancreas | 66% | 101.70 | 216 / 328 | 2% | 0.03 | 4 / 178 |
prostate | 65% | 100.62 | 159 / 245 | 3% | 0.05 | 13 / 502 |
blood vessel | 67% | 182.92 | 898 / 1335 | 0% | 0 | 0 / 0 |
breast | 64% | 97.38 | 294 / 459 | 2% | 0.11 | 21 / 1118 |
adipose | 61% | 153.99 | 740 / 1204 | 0% | 0 | 0 / 0 |
heart | 59% | 96.74 | 507 / 861 | 0% | 0 | 0 / 0 |
brain | 46% | 68.19 | 1225 / 2642 | 10% | 0.18 | 68 / 705 |
intestine | 47% | 76.21 | 450 / 966 | 2% | 0.16 | 11 / 527 |
bladder | 43% | 55.19 | 9 / 21 | 5% | 0.36 | 25 / 504 |
stomach | 35% | 71.72 | 125 / 359 | 1% | 0.03 | 4 / 286 |
tonsil | 0% | 0 | 0 / 0 | 24% | 1.07 | 11 / 45 |
muscle | 20% | 56.95 | 163 / 803 | 0% | 0 | 0 / 0 |
spleen | 19% | 22.48 | 45 / 241 | 0% | 0 | 0 / 0 |
liver | 9% | 20.94 | 20 / 226 | 0% | 0 | 0 / 406 |
eye | 0% | 0 | 0 / 0 | 8% | 0.10 | 6 / 80 |
peripheral blood | 4% | 7.67 | 40 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030216 | Biological process | keratinocyte differentiation |
GO_0018149 | Biological process | peptide cross-linking |
GO_0061436 | Biological process | establishment of skin barrier |
GO_0001533 | Cellular component | cornified envelope |
GO_0036457 | Cellular component | keratohyalin granule |
GO_0005829 | Cellular component | cytosol |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0005634 | Cellular component | nucleus |
GO_0005509 | Molecular function | calcium ion binding |
GO_0030280 | Molecular function | structural constituent of skin epidermis |
GO_0046914 | Molecular function | transition metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FLG |
Protein name | Alternative protein FLG Protein S100 (S100 calcium-binding protein) Profilaggrin Filaggrin Truncated profilaggrin |
Synonyms | |
Description | FUNCTION: Aggregates keratin intermediate filaments and promotes disulfide-bond formation among the intermediate filaments during terminal differentiation of mammalian epidermis. |
Accessions | Q4JFL9 I0B0K7 I0B0K6 Q03837 Q16824 L8E7P6 Q03839 ENST00000368799.2 I0B0K8 Q15206 I0B0K5 I0B0K3 P20930 I0B0K4 Q03838 |